Pepceuticals

Enderby, United Kingdom Founded: 1998 • Age: 28 yrs Acquired By Biosynth
Synthetic peptides are manufactured with custom synthesis services provided.

About Pepceuticals

Pepceuticals is a Healthcare company based in Enderby (United Kingdom) founded in 1998, and was acquired by Biosynth in September 2023. Synthetic peptides are manufactured with custom synthesis services provided. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides.

Company details

Pepceuticals was founded in 1998 as a British manufacturer specializing in synthetic peptides. Operations are based in Enderby, United Kingdom, where custom peptides for research applications are produced, along with synthesis reagents and resins. Expertise is applied to peptides up to 130 amino acids in length, supporting various scientific sectors through tailored synthesis processes.

  • Headquarters Enderby, United Kingdom
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website pepceuticals.co.uk
  • Social LinkedIn
  • Acquired by Biosynth (Sep 2023)
Key Metrics

Investors in Pepceuticals

Pepceuticals has secured backing from 1 investor. Prominent investors backing the company include Biosynth.

All
InvestorDescriptionFounded YearDomainLocation
Biosynth is engaged in supplying critical raw materials and services for life sciences and diagnostics.
1966biosynth.comThal, Switzerland
Premium access

Investor details for Pepceuticals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Pepceuticals

2 dated milestones of Pepceuticals across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pepceuticals is founded.
  2. Exit Acquired by Biosynth.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pepceuticals

Pepceuticals was founded in 1998.

Pepceuticals is headquartered in Enderby, United Kingdom. It is registered at Enderby, Leicestershire, United Kingdom.

Pepceuticals was founded in 1998 as a British manufacturer specializing in synthetic peptides. Operations are based in Enderby, United Kingdom, where custom peptides for research applications are produced, along with synthesis reagents and resins. Expertise is applied to peptides up to 130 amino acids in length, supporting various scientific sectors through tailored synthesis processes.

Pepceuticals has 1 investor. Key investors include Biosynth.

Yes. Pepceuticals was acquired by Biosynth in September 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available